Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q4 2025 Earnings

6NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-2.3

-1.59

-0.88

-0.17

Details

Expected EPS

-1.65835

Actual EPS

-2.19

Surprise EPS

-0.53

Surprise Percent

+32.06%

Description

Avalo Therapeutics (AVTX) has reported earnings of -2.19 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.